11-15 11-16 11-17
2024-11-15（Friday）08:30-13:00
展开
L1, Pearl Hall
Youth Forum
08:30-10:05

第一节 [Youth Forum]

主持： 钱鹏旭 浙江大学
Moderator： Pengxu Qian Zhejiang University
08:30-08:35

Opening

08:35-08:55

Proteome-Centric Multi-Omics Approach for Identifying Therapeutic Targets in Acute Myeloid Leukemia

王洪

中国医学科学院血液病医院

Hong Wang

Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
08:55-09:15

Targeting Cell Death to Augment Cancer Immunotherapy

潘荣清

浙江大学

Rongqing Pan

Zhejiang University
09:15-09:35

The Role and Clinical Application of NK Cells in Pregnancy Complication

傅斌清

中国科学技术大学

Binqing Fu

University of Science and Technology of China
09:35-09:55

Clonal Hematopoiesis of Indeterminate Potential Links Periodontitis and Inflammatory Comorbidities

王辉

四川大学

Hui Wang

Sichuan University
09:55-10:05

Coffee Break

10:05-13:00

第二节 [Youth Forum]

主持： 程辉 中国医学科学院血液病医院
Moderator： Hui Cheng Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
10:05-10:25

Single-cell Pan-leukemia Signatures of HSPC-like Blasts Predict Drug Response and Clinical Outcome

陈昌亚

中国医学科学院血液病医院

Changya Chen

Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
10:25-10:45

Production of Human Enucleated RBCs ex vivo: Mechanisms and Applications

刘森泉

中国科学技术大学

Senquan Liu

University of Science and Technology of China
10:45-11:05

Design and Functional Study of Synthetic Cytokines

任俊明

浙江大学

Junming Ren

Zhejiang University
11:05-11:25

The Heterogeneity and Regulatory Mechanisms of T cells in Autoimmune Diseases

陈坤

同济大学

Kun Chen

Tongji University
11:25-11:45

Precise Regulation of Type I Interferon Signaling in T.gondii-mediated Cancer Immunotherapy

余潇

南方医科大学

Xiao Yu

Southern Medical University
12:00-13:00

Lunch

2024-11-15（Friday）08:30-13:00
展开
L3, Diamond Ballroom 4+5
Industrial Development Forum 产业发展论坛 （中文）
08:30-10:40

第一节 [Industrial Development Forum 产业发展论坛 （中文）]

主持： 魏国庆 浙江大学医学院附属第一医院
Moderator： Guoqing Wei Zhejiang University
08:30-08:50

Opening and guest speech　开幕致辞

08:50-09:00

Exhibition Opening Ceremony　展商剪彩仪式

黄河 浙江大学 丨 Akihiro Shimosaka ACTO,Japan 丨 Arnon Nagler Sheba Medical Center, Israel 丨 Didier Blaise Institut Paoli Calmettes, France

He Huang Zhejiang University Akihiro Shimosaka ACTO,Japan Arnon Nagler Sheba Medical Center, Israel Didier Blaise Institut Paoli Calmettes, France

09:00-09:20

基于监管探讨细胞制剂的质量控制

梁锦锋

浙江省药品化妆品审评中心

Jinfeng Liang

Zhejiang Provincial Center for Drug and Cosmetic Evaluation
09:20-09:40

细胞和基因治疗临床研究的规范管理和申请流程

赵青威

浙江大学

Qingwei Zhao

Zhejiang University
09:40-10:00

MRD阴性率作为MM研究主要终点探讨

MRD negative rate as primary endpoint in MM clinical trials

陈杰

南京驯鹿生物医药有限公司

Jie Chen

Nanjing lASO Medical Technology Co.. Ltd.
10:00-10:20

Next Generation CAR-T Technologies for Hematopoietic Malignancies.

何晓文

原启生物科技（上海）有限责任公司

Peter He

Oricell Therapeutics Holdings Limited
10:20-10:40

Coffee Break

10:40-13:00

第二节 [Industrial Development Forum 产业发展论坛 （中文）]

主持： 胡永仙 浙江大学
Moderator： Yongxian Hu Zhejiang University
10:40-11:00

聚焦移植管线，重燃生命光彩

杨震

赛诺菲

Zhen Yang

Sanofi
11:00-11:20

中国细胞治疗药物的支付创新探索

Exploration of Payment Innovation for Cell Therapy Drugs in China

汪祥宁

复星凯瑞（上海）生物科技有限公司

Xiangning Wang

Shanghai Fosun Kairos Biotechnology Co., Ltd
11:20-11:40

Off-the-shelf Allogeneic CAR-T Cell Therapy for Autoimmune Diseases

郑彪

BRL Medicine Inc.

Biao Zheng

Shanghai Bangyao Biotechnology Co., Ltd
11:40-12:00

通用型 CAR-T 细胞的开发与展望

任江涛

南京北恒生物科技有限公司

Jiangtao Ren

Nanjing Beiheng Biotechnology Co., Ltd
12:00-13:00

Lunch

2024-11-15（Friday）13:30-17:30
展开
L1，Crystal Ballroom
Main venue A Plenary session I: Clinical & Translational Research
13:30-14:00

[Plenary session I: Clinical & Translational Research]

Opening ceremony [Main venue A Plenary session I: Clinical & Translational Research]

主持： 胡豫 华中科技大学同济医学院附属协和医院
Moderator： Yu Hu Concord Hospital affiliated with Tongji Medical College, Huazhong University of Science and Technology, China
致辞嘉宾： 黄河 浙江大学 丨 Mohamad Mohty Sorbonne University, France 丨 Akihiro Shimosaka ACTO,Japan
Guest speech： He Huang Zhejiang University 丨 Mohamad Mohty Sorbonne University, France 丨 Akihiro Shimosaka ACTO,Japan
14:00-16:00

第一节 [Plenary session I: Clinical & Translational Research]

主持： 胡豫 华中科技大学同济医学院附属协和医院 丨 周道斌 中国医学科学院北京协和医院
Moderator： Yu Hu Concord Hospital affiliated with Tongji Medical College, Huazhong University of Science and Technology, China 丨 Daobin Zhou Beijing Union Medical College Hospital, China
14:00-14:30

Novel Cellular Therapy for Hematological Malignant Diseases

黄河

浙江大学

He Huang

Zhejiang University
14:30-15:00

Using Marrow Infiltrating T cells to Treat Relapse After HSCT with PTCy

Leo Luznik

Baylor College of Medicine, USA

Leo Luznik

Baylor College of Medicine, USA
15:00-15:30

Points to Consider for Cellular Therapy

Akihiro Shimosaka

ACTO,Japan

Akihiro Shimosaka

ACTO,Japan
15:30-16:00

Coffee Break

16:00-17:30

第二节 [Plenary session I: Clinical & Translational Research]

主持： 刘启发 南方医科大学南方医院 丨 徐开林 徐州医科大学附属医院
Moderator： Qifa Liu Nanfang Hospital,Southern Medical University, China 丨 Kailin Xu Xuzhou Medical University Hospital, China
16:00-16:30

Type 2 Immunity May Hold Key to Long-term Cancer Remission

唐力

Swiss federal Institute of Technology in Lausanne，Switzerland

Li Tang

Swiss federal Institute of Technology in Lausanne，Switzerland
16:30-17:00

Integration of CAR-T into Total Therapy of Acute Lymphoblastic Leukemia

王建祥

中国医学科学院血液病医院

Jianxiang Wang

Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
17:00-17:30

Allogenic CAR-T Cell Therapy for Autoimmune Diseases

徐沪济

海军军医大学

Huji Xu

Naval Medical University
2024-11-15（Friday）13:00-17:30
展开
L3，Diamond Ballroom 4+5
Main venue B Plenary session II: Advances in Immune Cell Therapy
13:00-13:20

[Plenary session II: Advances in Immune Cell Therapy]

Opening ceremony [Main venue B Plenary session II: Advances in Immune Cell Therapy]

主持： 黄河 浙江大学 丨 许琛琦 中国科学院分子细胞科学卓越创新中心
Moderator： He Huang Zhejiang University 丨 Chenqi Xu Center for Excellence in Molecular Cell Science, CAS
13:25-15:40

第一节 [Plenary session II: Advances in Immune Cell Therapy]

主持： 王青青 浙江大学基础医学院 丨 王东睿 浙江大学
Moderator： Qingqing Wang Zhejiang University School of Medicine 丨 Dongrui Wang Zhejiang University
13:25-14:00

Myeloid-mediated Mechanisms of Resistance to Cancer Immunotherapy

Lawrence Fong

Fred Hutchinson Cancer Center, USA

Lawrence Fong

Fred Hutchinson Cancer Center, USA
14:00-14:35

Cell Injury and Tissue Homeostasis in Inflammatory Bowel Disease

陈家明

浙江大学

Jiaming Chen

Zhejiang University
14:35-15:00

Developing TCR-based Chimeric Antigen Receptor for Immunotherapy

林欣

清华大学

Xin Lin

Tsinghua University
15:00-15:25

Preclinical Assessment of the Efficacy andSafety of CAR-T Cell Therapy in Eosino-phil-associated Diseases

应颂敏

浙江大学

Songmin Ying

15:25-15:40

Coffee Break

15:40-17:30

第二节 [Plenary session II: Advances in Immune Cell Therapy]

主持： 陈伟 浙江大学 丨 蒋晞 浙江大学
Moderator： Jack Wei Chen School of Medicine, Zhejiang University 丨 Xi Jiang Zhejiang University
15:40-16:15

Harnessing Charge-mediated Immunoreceptor Signaling in T Cell Therapy

许琛琦

中国科学院分子细胞科学卓越创新中心

Chenqi Xu

Center for Excellence in Molecular Cell Science, CAS
16:15-16:40

CD7 CAR-T Bridged to allo-HSCT: Novel Strategies and Corresponding Mechanisms

胡永仙

浙江大学

Yongxian Hu

Zhejiang University
16:40-17:05

CAR-T Rational Design Driven by Artificial Intelligence

王皞鹏

上海科技大学

Haopeng Wang

ShanghaiTech University
17:05-17:30

Human T-cell Development and Aging

胡洪波

四川大学

Hongbo Hu

Sichuan University
2024-11-15（Friday）19:00-20:30
展开
L1，Crystal Ballroom
19:00-20:30

Welcome reception（L1，Crystal Ballroom／水晶宫）